Juan Roberto Sosa, MD
Psychiatry · Bakersfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Precision Psychiatric Services Inc · 19 clinicians in this group
Hospitals listed: Good Samaritan Hospital, Lp. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sosa’s office at (661) 215-7500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
California Medical Board record
Licence A163383 · Current
Licensed to practise in California · since 2019 · expires 2027-07-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan Hospital, LpBakersfield, CAAcute Care Hospital · Proprietary · No emergency departmentNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Good Samaritan Hospital, Lp
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 1 better, 1 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.59 to 1.51) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 145 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 694 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 738 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.76 to 5.93) · 141 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.24 (0.54 to 3.94) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0 to 1.89) · 489 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
Original Medicare doctor bills
$84,383
Medicare paid this office $84,383 for 99 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $60,872 | $62 |
| Psychiatric diagnostic evaluation with medical services | 92 | $17,071 | $131 |
| Hospital discharge day management, more than 30 minutes | 43 | $4,541 | $91 |
Who their Medicare patients are
99 Original Medicare patients in 2024. Average age 57 · Under 65 60% · Women 34% · Also on Medicaid 86% · Health risk score 2.03. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 75% · Depression 63% · Diabetes 34% · COPD 32% · Coronary heart disease 18% · Chronic kidney disease 17% · Heart failure 14% · Stroke 11%.
The office billed $277,916, Medicare allowed $106,578 and paid $84,383; for 1,182 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 99 | 1,182 | 57 | 2.03 | $277,916 | $84,383 |
| 2023 | 95 | 783 | 54 | 2.02 | $229,164 | $72,703 |
| 2022 | 190 | 1,095 | 62 | 3.01 | $369,811 | $107,002 |
| 2021 | 17 | 155 | 53 | 1.51 | $44,609 | $13,777 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $43,048 | $94 |
| Psychiatric diagnostic evaluation with medical services | 63 | $11,906 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $9,929 | $64 |
| Hospital discharge day management, more than 30 minutes | 39 | $4,161 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $3,659 | $94 |
2022: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $60,710 | $83 |
| Psychiatric diagnostic evaluation with medical services | 120 | $32,776 | $143 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $8,278 | $109 |
| Hospital discharge day management, more than 30 minutes | 49 | $4,728 | $86 |
2021: 1 service
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,451 | $112 |
Medicaid work
$65,381 in 2024
Medicaid paid $65,381 for 1,084 billed services this clinician did in 2024, up to 88 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Psychiatric diagnostic evaluation with medical services | 519 | $48,070 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 565 | $17,310 |
| 2024 | 1,084 | 2 | 88 | $65,381 |
| 2023 | 1,255 | 3 | 85 | $68,490 |
| 2022 | 1,004 | 2 | 104 | $99,447 |
| 2021 | 33 | 1 | 12 | $1,247 |
| 2020 | 425 | 3 | 45 | $56,056 |
| 2019 | 317 | 2 | 32 | $43,223 |
See the largest Medicaid services in earlier years
2023
| Psychiatric diagnostic evaluation with medical services | 456 | $43,915 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 490 | $14,905 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 309 | $9,670 |
2022
| Psychiatric diagnostic evaluation with medical services | 955 | $97,657 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 49 | $1,790 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 33 | $1,247 |
2020
| Clinic visit/encounter, all-inclusive | 243 | $56,056 |
| Short return visit (20+ min) | 168 | $0 |
| Return visit (30+ min) | 14 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 190 | $43,223 |
| Short return visit (20+ min) | 127 | $0 |
Drugs they prescribed that Part D paid
$7,900
Pharmacies billed $7,900 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 330) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
325 generic and fewer than 11 brand-name prescriptions · $7,900 in drug cost · 16 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atropine Sulfate | 11 | $436 | $40 |
| Divalproex Sodium Er | 17 | $423 | $25 |
| Olanzapine Odt | 11 | $322 | $29 |
| Divalproex | 23 | $294 | $13 |
| Clozapine | 12 | $281 | $23 |
See all 12 drugs
| Atropine Sulfate | 11 | $436 | $40 |
| Divalproex Sodium Er | 17 | $423 | $25 |
| Olanzapine Odt | 11 | $322 | $29 |
| Divalproex | 23 | $294 | $13 |
| Clozapine | 12 | $281 | $23 |
| Haloperidol | 19 | $242 | $13 |
| Gabapentin | 33 | $190 | $6 |
| Trazodone | 33 | $89 | $3 |
| Olanzapine | 12 | $46 | $4 |
| Risperidone | 13 | $43 | $3 |
| Levothyroxine | 18 | $33 | $2 |
| Fluoxetine | 12 | $23 | $2 |
Year by year
| 2024 | 330 | 76 | 0% (0) | None | $7,900 |
| 2023 | 449 | 99 | 0% (0) | 3% | $10,405 |
| 2022 | 350 | 77 | 0% (0) | None | $5,675 |
| 2021 | 393 | 72 | 0% (0) | 11% | $36,050 |
| 2020 | 845 | 59 | None | 6% | $85,397 |
| 2019 | 258 | 28 | 0% (0) | 5% | $19,837 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Olanzapine Odt | 17 | $1,312 | $77 |
| Acamprosate | 12 | $1,166 | $97 |
| Divalproex Sodium Er | 19 | $1,081 | $57 |
| Divalproex | 33 | $625 | $19 |
| Risperidone | 55 | $556 | $10 |
| Gabapentin | 49 | $554 | $11 |
| Olanzapine | 20 | $413 | $21 |
| Clozapine | 23 | $300 | $13 |
| Trazodone | 39 | $239 | $6 |
| Quetiapine | 12 | $118 | $10 |
| Lorazepam | 11 | $66 | $6 |
| Mirtazapine | 11 | $30 | $3 |
2022: 7 drugs
| Divalproex Sodium Er | 15 | $956 | $64 |
| Olanzapine | 43 | $733 | $17 |
| Gabapentin | 36 | $704 | $20 |
| Divalproex | 25 | $331 | $13 |
| Quetiapine | 21 | $258 | $12 |
| Risperidone | 23 | $210 | $9 |
| Trazodone | 41 | $133 | $3 |
2021: 10 drugs
| Invega Sustenna | 13 | $29,222 | $2,248 |
| Olanzapine | 39 | $605 | $16 |
| Divalproex Sodium Er | 21 | $509 | $24 |
| Divalproex | 11 | $340 | $31 |
| Quetiapine | 23 | $188 | $8 |
| Gabapentin | 23 | $161 | $7 |
| Risperidone | 20 | $135 | $7 |
| Lithium Carbonate | 14 | $95 | $7 |
| Trazodone | 27 | $86 | $3 |
| Benztropine Mesylate | 11 | $69 | $6 |
2020: 26 drugs
| Invega Sustenna | 27 | $58,935 | $2,183 |
| Aripiprazole | 15 | $3,128 | $209 |
| Venlafaxine Hcl Er | 20 | $1,722 | $86 |
| Divalproex Sodium Er | 28 | $1,691 | $60 |
| Gabapentin | 49 | $1,471 | $30 |
| Trazodone | 99 | $884 | $9 |
| Quetiapine | 70 | $581 | $8 |
| Olanzapine | 53 | $493 | $9 |
| Ziprasidone | 13 | $468 | $36 |
| Fluoxetine | 48 | $366 | $8 |
| Mirtazapine | 21 | $359 | $17 |
| Fluvoxamine Maleate | 13 | $353 | $27 |
| Prazosin | 19 | $352 | $19 |
| Bupropion Xl | 18 | $331 | $18 |
| Risperidone | 31 | $246 | $8 |
| Escitalopram | 28 | $211 | $8 |
| Benztropine Mesylate | 18 | $191 | $11 |
| Duloxetine | 11 | $181 | $16 |
| Clonazepam | 29 | $173 | $6 |
| Sertraline | 36 | $132 | $4 |
| Propranolol | 11 | $129 | $12 |
| Topiramate | 11 | $106 | $10 |
| Paroxetine | 15 | $104 | $7 |
| Citalopram Hbr | 11 | $79 | $7 |
| Hydroxyzine | 14 | $75 | $5 |
| Lorazepam | 11 | $71 | $6 |
2019: 7 drugs
| Gabapentin | 19 | $1,106 | $58 |
| Quetiapine | 30 | $842 | $28 |
| Trazodone | 31 | $385 | $12 |
| Risperidone | 12 | $356 | $30 |
| Olanzapine | 14 | $75 | $5 |
| Fluoxetine | 14 | $49 | $4 |
| Sertraline | 13 | $36 | $3 |
Money from drug and device companies
$866 in 2025
| 2025 | 5 | 7 | None | $866 |
| 2024 | 3 | 4 | None | $498 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alkermes | Lybalvi | $372 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $139 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $125 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $121 | 1 payment
|
| Teva Pharmaceuticals USA | Uzedy | $108 | 1 payment
|
See all 7 published payments
| Otsuka America Pharmaceutical | Meals · 2025-11-13 | Rexulti | $125 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-06 | Caplyta | $121 |
| Alkermes | Meals · 2025-10-16 | Lybalvi | $123 |
| Teva Pharmaceuticals USA | Meals · 2025-09-18 | Uzedy | $108 |
| Alkermes | Meals · 2025-07-16 | Lybalvi | $124 |
| Alkermes | Meals · 2025-05-14 | Aristada | $125 |
| Janssen Pharmaceuticals | Meals · 2025-03-26 | Invega Sustenna | $139 |
See earlier years (2024)
2024: $498
| Alkermes | Lybalvi | $244 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $128 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $125 | 1 payment
|
Professional record
- NPI
- 1104351923
- Licence
- CA A163383California A163383: Current · expires 2027-07-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 7850 White Ln Ste E301, Bakersfield, CA, 93309
- NPI first listed
- 2017-04-30
- NPI last updated
- 2023-07-12
- NPI record certified
- 2023-07-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2416 W Shaw Ave Ste 114, Fresno, CA, 93711 · 496 S Barton Ave, Fresno, CA, 93702 · 301 E 13th St Ste D, Merced, CA, 95341 · 455 Silicon Valley Blvd, San Jose, CA, 95138